Merck KGaA Apr 1, 2026 Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business - Merck Group
FierceBiotech Mar 25, 2026 Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Endpoints News Mar 25, 2026 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News Mar 24, 2026 Merck partners with Flagship startup Quotient to search for genetic clues to IBD
FierceBiotech Mar 6, 2026 Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
BioPharma Dive Feb 12, 2026 Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo